{Reference Type}: Journal Article
{Title}: A Review of Canaloplasty in the Treatment and Management of Glaucoma.
{Author}: Wagner IV;Towne C;Saade MC;Lentz PC;Rashedi A;Vasu P;Boopathiraj N;Checo L;Krambeer C;Miller DD;Dorairaj S;
{Journal}: J Curr Glaucoma Pract
{Volume}: 18
{Issue}: 2
{Year}: 2024 Apr-Jun
暂无{DOI}: 10.5005/jp-journals-10078-1442
{Abstract}: <B>UNASSIGNED: </B>To review the published literature evaluating the safety and efficacy outcomes of canaloplasty performed in the treatment of glaucoma.<BR><B>UNASSIGNED: </B>Canaloplasty is a nonpenetrating glaucoma procedure involving combined 360° circumnavigation and viscodilation of Schlemm's canal. The procedure may be performed under an ab externo (with tensioning suture) or ab-interno (conjunctiva-sparing) approach. Given the wide variety of glaucoma procedure types and approaches, further investigation into the role of canaloplasty in ophthalmological practice is warranted. The objectives of this narrative review are to synthesize the existing literature in order to investigate indications, safety and efficacy outcomes, and the optimal place of canaloplasty in glaucoma treatment and management.<BR><B>UNASSIGNED: </B>A total of 60 articles were included in this review. Both ab externo and ab-interno canaloplasty (ABiC) were found to be significantly effective at reducing intraocular pressure (IOP) and glaucoma medication burdens in patients with mild-to-moderate open-angle glaucoma (OAG). These findings remained consistent regardless of phacoemulsification status. ABiC was found to exhibit a safety profile favorable compared to trabeculectomy and comparable to minimally invasive trabecular bypass implants.<BR><B>UNASSIGNED: </B>Canaloplasty is a nonpenetrating surgical intervention that is highly effective in treating patients with mild-to-moderate OAG across a large variety of clinical scenarios.<BR><B>UNASSIGNED: </B>These findings support the clinical use of canaloplasty in ophthalmological practice, clarify its patient profile, and compare procedural outcomes to other minimally invasive glaucoma surgery (MIGS) devices on the market.<BR><B>UNASSIGNED: </B>Wagner IV, Towne C, Saade MC, et al. A Review of Canaloplasty in the Treatment and Management of Glaucoma. J Curr Glaucoma Pract 2024;18(2):79-85.